Combination therapy of a type II anti-CD20 antibody with a selective Bcl-2 inhibitor | Patent Publication Number 20140248262

US 20140248262 A1
Patent NumberUS 09539251 B2
Application Number14020761
Filled DateSep 6, 2013
Priority DateSep 7, 2012
Publication DateSep 4, 2014
Original AssigneeRoche
Current AssigneeAbbvie Inc.
Genentech Inc
Inventor/ApplicantsDeepak Sampath
Christian Klein
Wayne John Fairbrother
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.